#CJMB

StockTitan

@stocktitan.net

5 days ago

Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s IND Clinical Trials for lodonal™ in the Treatment of Long COVID Callan JMB (NASDAQ: CJMB) will oversee manufacturing, quality assurance, and distribution governance for Attune Biotech's investigational drug lodonal™ (JKB-122) under IND 181314 for the treatment of Long COVID.Services include CMO qualification, batch record review, supply chain verification, surge capacity assessment, and distribution pathway validation. Attune plans a randomized Phase 2b/3 trial; lodonal™ remains investigational and is protected by IP through 2041.

#CJMB Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s IND Clinical Trials for lodonal™ in the Treatment of Long COVID

www.stocktitan.net/news/CJMB/callan-jmb-inc...

StockTitan

@stocktitan.net

1 month ago

Callan JMB Announces Participation in the DealFlow Discovery Conference on January 28-29, 2026 Callan JMB (NASDAQ:CJMB) will participate in the DealFlow Discovery Conference on January 28-29, 2026 at The Borgata, Atlantic City, NJ. The company is scheduled to present on Wednesday, January 28 at 3:00pm in Room #3. Callan JMB provides fulfillment, storage, monitoring, and cold chain logistics services for healthcare and emergency management agencies. For attendance or media queries, contact your DealFlow representative or email CallanJMB@kcsa.com.

#CJMB Callan JMB Announces Participation in the DealFlow Discovery Conference on January 28-29, 2026

www.stocktitan.net/news/CJMB/callan-jmb-ann...

Nasdaq

@nasdaq.activitypub.awakari.com.ap.brid.gy

2 months ago

Nasdaq Surges Over 100 Points; M&T Bank Posts Upbeat Earnings - Callan Jmb (NASDAQ:CJMB), Jeffs Brands (NASDAQ:JFBR)

Nasdaq Surges Over 100 Points; M&T Bank Posts Upbeat Earnings read more

#CJMB #Earnings #Equities #JFBR #LCFY #Mid #Morning #Market #Update #MTB #News

Origin | Interest | Match

StockTitan

@stocktitan.net

4 months ago

Callan JMB Announces Third Quarter 2025 Financial Results and Provides Business Update Callan JMB (NASDAQ:CJMB) reported third-quarter results for the period ended September 30, 2025 and provided a business update. Q3 revenue was $1.4M and nine-month revenue was $4.6M. Gross profit was $0.5M for Q3 and $1.8M year-to-date. Operating loss was ($1.9M) in Q3 and ($4.5M) for nine months; cash totaled $2.8M at September 30, 2025.Business developments include a $1.5M funding increase to extend the City of Chicago emergency-preparedness contract to June 2026 (total contract value $9.1M), formation of an India subsidiary with planned temperature-controlled pharmaceutical warehousing, a preliminary agreement to install oral drug delivery equipment at its Texas cGMP facility, expansion into food sampling, and an upgrade of its Sentry Monitoring System to v4.0 (HTML5).

#CJMB Callan JMB Announces Third Quarter 2025 Financial Results and Provides Business Update

www.stocktitan.net/news/CJMB/callan-jmb-ann...

StockTitan

@stocktitan.net

4 months ago

Callan JMB Enters Agreement to Install Oral Drug Delivery Equipment in Texas Facility Callan JMB (NASDAQ:CJMB) entered a preliminary agreement on November 13, 2025 to install an oral drug delivery manufacturer's production equipment at its cGMP facility in Spring Branch, Texas. The collaboration begins a phased effort to combine Callan JMB's cGMP warehousing, licensing, certification, and distribution capabilities with the client's manufacturing technology for fast-dissolving oral strips that offer an alternative to intravenous injections.The companies are negotiating operational terms while Callan JMB positions this move as part of broader onshoring and manufacturing initiatives with global healthcare partners, including planned efforts with Revival Health.

#CJMB Callan JMB Enters Agreement to Install Oral Drug Delivery Equipment in Texas Facility

www.stocktitan.net/news/CJMB/callan-jmb-ent...

StockTitan

@stocktitan.net

4 months ago

Callan JMB Expands Logistics Platform Into Food Sampling Sector, Advancing Multi-Variant Growth Strategy Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company serving

#CJMB Callan JMB Expands Logistics Platform Into Food Sampling Sector, Advancing Multi-Variant Growth Strategy

www.stocktitan.net/news/CJMB/callan-jmb-exp...

StockTitan

@stocktitan.net

5 months ago

Callan JMB Upgrades Sentry Monitoring System Technology with Sentry 4 for Mobile Temperature Monitoring Callan JMB (NASDAQ:CJMB) announced Sentry 4.0, an upgraded version of its Sentry Monitoring System for temperature-sensitive pharmaceutical storage on Oct 13, 2025.Sentry 4.0 replaces Java with HTML5, enabling access from any web browser on PC, Mac, iPhone, Android, or tablet without downloads. The system retains 24/7/365 active monitoring, alarm notifications, and compliant reporting while improving user accessibility and consistency across devices. The upgrade is available now to new and existing customers.

#CJMB Callan JMB Upgrades Sentry Monitoring System Technology with Sentry 4 for Mobile Temperature Monitoring

www.stocktitan.net/news/CJMB/callan-jmb-upg...

StockTitan

@stocktitan.net

5 months ago

Callan JMB Announces Participation in the LD Micro Main Event XIX Conference on October 19-21, 2025 Callan JMB (NASDAQ: CJMB) announced that its management team will participate in the LD Micro Main Event XIX on October 19-21, 2025. Presentation is scheduled for October 21, 2025 at 12:00 PM PT at Hotel del Coronado, San Diego, CA. A live webcast will be available at https://ldmicrocasts.com/. For access or questions, contact your LD Micro representative or email CallanJMB@kcsa.com.

#CJMB Callan JMB Announces Participation in the LD Micro Main Event XIX Conference on October 19-21, 2025

www.stocktitan.net/news/CJMB/callan-jmb-ann...

StockTitan

@stocktitan.net

7 months ago

Callan JMB Announces Second Quarter 2025 Financial Results and Provides Business Update Callan JMB (NASDAQ: CJMB), a healthcare logistics company, reported Q2 2025 financial results and significant business developments. The company recorded Q2 revenues of $1.7 million and a net loss from operations of $1.4 million.Key developments include a strategic partnership with Revival Health for integrated supply chain services, launch of an Indian subsidiary with planned temperature-controlled facilities in Pune, and extension of Chicago's emergency preparedness contract through June 2026 with a $1.5 million funding increase to $9.1 million total. The company also appointed Christopher Shields as SVP of Emergency Preparedness & Response and successfully managed a measles outbreak response.Post-quarter, Callan JMB secured a $25 million equity line of credit to support growth initiatives in GLP-1 pharmaceutical distribution, specialty compounding pharmacy logistics, and premium food packaging solutions.

#CJMB Callan JMB Announces Second Quarter 2025 Financial Results and Provides Business Update

www.stocktitan.net/news/CJMB/callan-jmb-ann...

StockTitan

@stocktitan.net

7 months ago

Callan JMB Extends Long-Term Contract with City of Chicago and Receives Increase in Funding Callan JMB (NASDAQ: CJMB) has secured a contract extension with the City of Chicago through June 2026, marking a significant development in their seven-year partnership. The contract, focused on Health Preparedness Supplies and Related Services, includes a $1.5 million funding increase, bringing the total contract value to $9.1 million.Through its subsidiary Coldchain Technology Services, Callan JMB will continue providing pallet storage and emergency supplies management services for Chicago residents. The extension ensures uninterrupted service delivery in emergency preparedness and response capabilities.

#CJMB Callan JMB Extends Long-Term Contract with City of Chicago and Receives Increase in Funding

www.stocktitan.net/news/CJMB/callan-jmb-ext...

StockTitan

@stocktitan.net

8 months ago

Callan JMB Inc. Launches Subsidiary in India and Progresses to Establish Temperature-Controlled Warehouse Callan JMB (NASDAQ: CJMB) has established a new subsidiary, Callan JMB Services (India) Private Limited, to expand its logistics services in India. The company plans to open a temperature-controlled warehouse in Pune, Maharashtra capable of storing pharmaceuticals at various temperatures, including -80°C for tissue samples.The subsidiary, incorporated on June 20, 2025, will facilitate pharmaceutical distribution within India and help Indian companies establish manufacturing operations in the U.S. The company has already secured an agreement with Walker's Pharmaceuticals and is collaborating with Brihans Natural Products for U.S. manufacturing setup and distribution services.

#CJMB Callan JMB Inc. Launches Subsidiary in India and Progresses to Establish Temperature-Controlled Warehouse

www.stocktitan.net/news/CJMB/callan-jmb-inc...

StockTitan

@stocktitan.net

9 months ago

Emergency Response: How Callan JMB's Cold Chain Tech Delivered 1,300 Measles Vaccines to Combat Outbreak Specialized cold chain technology enables critical vaccine redistribution from Chicago to Texas and New Mexico. Zero-waste operation supports urgent public health response. Learn more.

#CJMB Callan JMB Supports Texas and New Mexico with Measles Outbreak Response through Redistribution of MMR II Vaccines

www.stocktitan.net/news/CJMB/callan-jmb-sup...

StockTitan

@stocktitan.net

9 months ago

Healthcare Supply Chain Breakthrough: Callan JMB Joint Venture Transforms U.S. Wellness Product Distribution New partnership combines logistics expertise with health tech innovation to revolutionize wellness product distribution. Strategic alliance promises nationwide impact. Learn more.

#CJMB Callan JMB and Revival Health Form Joint Venture to Strengthen U.S. Supply Chain for Vital Health, Wellness and Longevity Products

www.stocktitan.net/news/CJMB/callan-jmb-and...

StockTitan

@stocktitan.net

10 months ago

Callan JMB Announces First Quarter 2025 Financial Results and Provides Business Update Callan JMB (NASDAQ: CJMB), a healthcare and emergency management logistics company, reported its Q1 2025 financial results following its February IPO. The company raised $5.7 million through its IPO at $4.00 per share. Q1 2025 financial results showed revenue of $1.45 million, with a gross profit margin of 42.5%, but reported a net loss of $1.2 million due to increased SG&A expenses and declining emergency preparedness service demand.Key developments include appointing Christopher Shields as SVP of Emergency Preparedness & Response, renewing contracts with Texas DSHS, securing a five-year contract with Oregon Health Authority, and launching a vaccine management lease program. The company is expanding into GLP-1 pharmaceutical transportation, specialized compounding pharmacy logistics, and premium food packaging services.

#CJMB Callan JMB Announces First Quarter 2025 Financial Results and Provides Business Update

www.stocktitan.net/news/CJMB/callan-jmb-ann...

StockTitan

@stocktitan.net

10 months ago

Healthcare Logistics Leader Callan JMB Reveals Growth Strategy at Major Investor Conference Next Week Get exclusive insights into Callan JMB's healthcare logistics expansion plans at upcoming Aegis Capital virtual presentation. Register now for investor access.

#CJMB Callan JMB Announces Participation in the Aegis Capital Corp. Virtual Conference 2025 on May 21, 2025 

www.stocktitan.net/news/CJMB/callan-jmb-ann...

StockTitan

@stocktitan.net

11 months ago

Healthcare Logistics Leader Callan JMB Reveals Growth Strategy at Elite Investor Conference Healthcare logistics innovator Callan JMB showcases growth opportunities at LD Micro conference. Management available for 1-on-1 meetings. Live webcast available.

#CJMB Callan JMB Announces Participation in LD Micro Invitational Conference on April 9-10th in New York City

www.stocktitan.net/news/CJMB/callan-jmb-ann...

StockTitan

@stocktitan.net

11 months ago

Callan JMB Announces Full Year 2024 Financial Results and Provides Business Update Callan JMB (NASDAQ: CJMB), a logistics company specializing in healthcare and emergency management, reported its full year 2024 financial results. The company successfully completed its IPO on February 6, 2025, raising approximately $5.7 million at $4.00 per share.Key financial metrics for 2024 include:Total revenue: $6.6 million ($3.8M from emergency response, $2.8M from specialty packaging)Gross profit: $2.6 million with 39.1% marginOperating loss: $2.3 millionNet loss: $2.3 millionNotable achievements include extending arrangements with Texas DSHS, securing a five-year contract with Oregon Health Authority, launching a vaccine management lease program, and joining Complete Group Services. Revenue was impacted by reduced emergency preparedness services post-COVID and a temporary suspension of orders from one customer.

#CJMB Callan JMB Announces Full Year 2024 Financial Results and Provides Business Update

www.stocktitan.net/news/CJMB/callan-jmb-ann...

StockTitan

@stocktitan.net

1 year ago

How Will Callan JMB's Emergency Response to Texas Measles Crisis Impact Its Bottom Line? Texas health officials call on Callan JMB's emergency services amid measles outbreak. Company mobilizing 24/7 staff under its 5-year contingency contract for vaccine distribution.

#CJMB Callan JMB Receives Request from the State of Texas Department of Health and Human Services to be on Standby in Response to Measles Outbreak

www.stocktitan.net/news/CJMB/callan-jmb-rec...

StockTitan

@stocktitan.net

1 year ago

How Callan JMB's New Vaccine Program Saves Healthcare Organizations $100,000 in Equipment Costs Comprehensive immunization management solution includes refrigerators, freezers, and monitoring systems with proven success managing 2.27M COVID vaccine doses.

#CJMB Callan JMB Unveils Innovative Immunization Management Infrastructure Lease Program for Government Agencies and Private Organizations

www.stocktitan.net/news/CJMB/callan-jmb-unv...

StockTitan

@stocktitan.net

1 year ago

Emergency Response Giant CJMB Lands Massive Oregon Contract: 800K Vaccines, 75K Miles Covered Callan JMB wins renewed 5-year Oregon Health Authority contract following successful handling of 800,000 vaccines across 75,000 miles during COVID-19 crisis.

#CJMB Callan JMB Awarded Second 5-Year Contract by the Oregon Health Authority for Emergency Preparedness and Response after Successful Operations for COVID-19 and MPOX Pandemics

www.stocktitan.net/news/CJMB/callan-jmb-awa...